Clinical Trial

Change in Serum Biomarkers After Endovascular Treatment for Acute Anterior Circulation Large Vessel Occlusion

Recruiting
View on ClinicalTrials.gov →
Summary
Acute ischaemic stroke (AIS) results in high rates of neurological morbidity and mortality, especially in patients with large vessel occlusion (LVO). Endovascular therapy (EVT) has been approved as the most effective treatment for patients with LVO , but about half patients undergoing EVT did not achieve good outcome. The mechanisms of poor prognosis are complex. How to accurately identify serological biomarkers related to patients' clinical prognosis is an important research topic nowadays.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-04-20; most recent amendment 2025-08-20.
Status change: Not Yet Recruiting → Recruiting 2024-07-06
Trial Details
NCT Number NCT06383182
Lead Sponsor General Hospital of Shenyang Military Region
Conditions Ischemic Stroke
Enrollment 200 participants
Start Date 2024-07-02
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-21